GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Epigral Ltd (BOM:543332) » Definitions » Total Stockholders Equity

Epigral (BOM:543332) Total Stockholders Equity : ₹12,541 Mil (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Epigral Total Stockholders Equity?

Epigral's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ₹12,541 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Epigral's Book Value per Share for the quarter that ended in Mar. 2024 was ₹301.83. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Epigral's Debt-to-Equity for the quarter that ended in Mar. 2024 was 0.77.


Epigral Total Stockholders Equity Historical Data

The historical data trend for Epigral's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Epigral Total Stockholders Equity Chart

Epigral Annual Data
Trend Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Total Stockholders Equity
Get a 7-Day Free Trial 5,834.71 6,841.34 7,259.70 10,691.00 12,541.01

Epigral Quarterly Data
Mar18 Mar19 Mar20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10,691.00 - 11,283.30 - 12,541.01

Epigral  (BOM:543332) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Epigral's Book Value per Share for the quarter that ended in Mar. 2024 is

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Epigral's Debt-to-Equity for the quarter that ended in Mar. 2024 is

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Epigral Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Epigral's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Epigral (BOM:543332) Business Description

Traded in Other Exchanges
Address
Corporate Road, 5th Floor, 6th Floor & 7th Floor, Meghmani House, Behind Safal Profitaire, Prahladnagar, Ahmedabad, GJ, IND, 380015
Epigral Ltd Formerly Meghmani Finechem Ltd is a producer of Chlor-Alkali and its Derivatives and specialty chemicals with backward and forward integration facilities. It manufactures Caustic Soda, Caustic Potash, CPVC Resin, Epichlorohydrin, Chlorine, Hydrogen, Chloromethanes, and Hydrogen Peroxide. The company is focused on servicing domestic as well as international markets.

Epigral (BOM:543332) Headlines

No Headlines